North Texas Clinical Trials and Greater Gift to Celebrate Clinical Trial Participants

WINSTON SALEM, NC – June 14 – 2022 – North Texas Clinical Trials (NTXCT) and Greater Gift announced today a new partnership that will aim to improve patient engagement and retention, create awareness, and engage diverse populations in clinical research.

As part of the agreement, NTXCT will honor 250 clinical trial participants with a donation that will make possible a certificate of honor for each participant as well as a corresponding donation of a food stuffed backpack to Feeding America to support the Tarrant County Food Bank.

“We are extremely grateful to North Texas Clinical Trials for their generosity and participation in our efforts to make clinical trial participation more accessible to diverse populations,” said Lilly Bunch, Executive Director of Greater Gift.

“We are thrilled to celebrate and honor clinical trial volunteers and their families by doubling their impact and giving back to our community through donations to our local Tarrant County Food Bank,” said Tamara Nelson, Clinical Operations Director of NTXCT. “It is often years before trial volunteers see the impact of their participation. It is exciting to be able to provide them with tangible evidence of their contributions. We are grateful for the opportunity to partner with Greater Gift and will continue to support their mission to change the face of research by informing, advocating, and supporting our communities” said Jessica Anderson, Site Director of NTXCT.

About North Texas Clinical Trials: North Texas Clinical Trials is an independent clinical trials site, located in Fort Worth, Texas, with a mission to provide quality data through trusted care. Comprised of experienced and dedicated staff, collectively having decades of experience in medical device and pharmaceutical drug trials ranging from phase I-IV across a wide range of therapeutic areas. NTXCT continues to effectively combine strategic volunteer recruitment and retention with exceptional, high-quality clinical trial conduct.